Clinical research of intralesional sclerotherapy in the oral and maxillofacial region

Clinical research for safty and efficacy in intralesional sclerotherapy with ethanolamine oleate for subcutaneous venous malformation in the oral and maxillofacial region - EOST-OMS

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs071180067

Enrollment

Registered

2019-03-20

Start date

2009-10-23

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous malformation in the oral and maxillofacial region Sclerotherapy, Venous malformation, ethanolamine oleate

Interventions

Single arm study, open (masking not used), no assignment All procedures will be done with oral surgeon and radiologist in angiography room. (For superficial lesion, procedures will be done with interm

sclerotherapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Venous malformation in the oral and maxillofacial region 2.Low-flow venous malformation diagnosed in contrasted MRI or CT 3.Both gender, any age 4.Written informed consent (<20 patients; Written informed consent by guardians)

Exclusion criteria

Exclusion criteria: 1.24hCCr<70L/day or Creatinine Clearance estimate <60 ml/min 2.Unfit for the clinical research 3.Uncooperative for the treatments under local anesthesia

Design outcomes

Secondary

Measure	Time frame
Adverse events: rate, details, severity, recurrence rate	—

Primary

Measure	Time frame
Reduction rate	—

Contacts

Public ContactReona Aijima

Saga University

f8197@cc.saga-u.ac.jp+81-952-34-2397

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026